TY - INPR A1 - Höbartner, Claudia A1 - Steinmetzger, Christian A1 - Palanisamy, Navaneethan A1 - Gore, Kiran R. T1 - A multicolor large Stokes shift fluorogen-activating RNA aptamer with cationic chromophores T2 - Chemistry - A European Journal N2 - Large Stokes shift (LSS) fluorescent proteins (FPs) exploit excited state proton transfer pathways to enable fluorescence emission from the phenolate intermediate of their internal 4 hydroxybenzylidene imidazolone (HBI) chromophore. An RNA aptamer named Chili mimics LSS FPs by inducing highly Stokes-shifted emission from several new green and red HBI analogs that are non-fluorescent when free in solution. The ligands are bound by the RNA in their protonated phenol form and feature a cationic aromatic side chain for increased RNA affinity and reduced magnesium dependence. In combination with oxidative functional-ization at the C2 position of the imidazolone, this strategy yielded DMHBO\(^+\), which binds to the Chili aptamer with a low-nanomolar K\(_D\). Because of its highly red-shifted fluorescence emission at 592 nm, the Chili–DMHBO\(^+\) complex is an ideal fluorescence donor for Förster resonance energy transfer (FRET) to the rhodamine dye Atto 590 and will therefore find applications in FRET-based analytical RNA systems. KW - RNA Aptamer KW - fluorescence KW - large Stokes shift KW - fluorescent protein KW - fluorescent resonance energy transfer Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-174197 N1 - This is the pre-peer reviewed version of the following article: Steinmetzger, C. , Palanisamy, N. , Gore, K. . and Höbartner, C. (2018), A multicolor large Stokes shift fluorogen‐activating RNA aptamer with cationic chromophores. Chem. Eur. J. doi:10.1002/chem.201805882, which has been published in final form at https://doi.org/10.1002/chem.201805882. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. ER - TY - JOUR A1 - Okuda, Takumi A1 - Lenz, Ann-Kathrin A1 - Seitz, Florian A1 - Vogel, Jörg A1 - Höbartner, Claudia T1 - A SAM analogue-utilizing ribozyme for site-specific RNA alkylation in living cells JF - Nature Chemistry N2 - Post-transcriptional RNA modification methods are in high demand for site-specific RNA labelling and analysis of RNA functions. In vitro-selected ribozymes are attractive tools for RNA research and have the potential to overcome some of the limitations of chemoenzymatic approaches with repurposed methyltransferases. Here we report an alkyltransferase ribozyme that uses a synthetic, stabilized S-adenosylmethionine (SAM) analogue and catalyses the transfer of a propargyl group to a specific adenosine in the target RNA. Almost quantitative conversion was achieved within 1 h under a wide range of reaction conditions in vitro, including physiological magnesium ion concentrations. A genetically encoded version of the SAM analogue-utilizing ribozyme (SAMURI) was expressed in HEK293T cells, and intracellular propargylation of the target adenosine was confirmed by specific fluorescent labelling. SAMURI is a general tool for the site-specific installation of the smallest tag for azide-alkyne click chemistry, which can be further functionalized with fluorophores, affinity tags or other functional probes. KW - Alkyltransferase Ribozyme SAMURI KW - Site-specific RNA labelling KW - bioorthogonal SAM analogue ProSeDMA KW - Chemical modification KW - RNA Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-328762 ER - TY - INPR A1 - Maghami, Mohammad Ghaem A1 - Scheitl, Carolin P. M. A1 - Höbartner, Claudia T1 - Direct in vitro selection of trans-acting ribozymes for posttranscriptional, site-specific, and covalent fluorescent labeling of RNA T2 - Journal of the American Chemical Society N2 - General and efficient tools for site-specific fluorescent or bioorthogonal labeling of RNA are in high demand. Here, we report direct in vitro selection, characterization, and application of versatile trans-acting 2'-5' adenylyl transferase ribozymes for covalent and site-specific RNA labeling. The design of our partially structured RNA pool allowed for in vitro evolution of ribozymes that modify a predetermined nucleotide in cis (i.e. intramolecular reaction), and were then easily engineered for applications in trans (i.e. in an intermolecular setup). The resulting ribozymes are readily designed for specific target sites in small and large RNAs and accept a wide variety of N6-modified ATP analogues as small molecule substrates. The most efficient new ribozyme (FH14) shows excellent specificity towards its target sequence also in the context of total cellular RNA. KW - covalent and site-specific RNA labeling KW - trans-acting 2'-5' adenylyl transferase ribozymes KW - in vitro selection from a structured RNA library KW - Ribozyme-catalyzed RNA labeling KW - intermolecular applications of ribozymes Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-192333 N1 - This document is the unedited Author’s version of a Submitted Work that was subsequently accepted for publication in Journal of the American Chemical Society, copyright © American Chemical Society after peer review. To access the final edited and published work see https://doi.org/10.1021/jacs.9b10531. ER - TY - JOUR A1 - Ronald, Micura A1 - Höbartner, Claudia T1 - Fundamental studies of functional nucleic acids: aptamers, riboswitches, ribozymes and DNAzymes JF - Chemical Society Reviews N2 - This review aims at juxtaposing common versus distinct structural and functional strategies that are applied by aptamers, riboswitches, and ribozymes/DNAzymes. Focusing on recently discovered systems, we begin our analysis with small-molecule binding aptamers, with emphasis on in vitro-selected fluorogenic RNA aptamers and their different modes of ligand binding and fluorescence activation. Fundamental insights are much needed to advance RNA imaging probes for detection of exo- and endogenous RNA and for RNA process tracking. Secondly, we discuss the latest gene expression–regulating mRNA riboswitches that respond to the alarmone ppGpp, to PRPP, to NAD+, to adenosine and cytidine diphosphates, and to precursors of thiamine biosynthesis (HMP-PP), and we outline new subclasses of SAM and tetrahydrofolate-binding RNA regulators. Many riboswitches bind protein enzyme cofactors that, in principle, can catalyse a chemical reaction. For RNA, however, only one system (glmS ribozyme) has been identified in Nature thus far that utilizes a small molecule – glucosamine-6-phosphate – to participate directly in reaction catalysis (phosphodiester cleavage). We wonder why that is the case and what is to be done to reveal such likely existing cellular activities that could be more diverse than currently imagined. Thirdly, this brings us to the four latest small nucleolytic ribozymes termed twister, twister-sister, pistol, and hatchet as well as to in vitro selected DNA and RNA enzymes that promote new chemistry, mainly by exploiting their ability for RNA labelling and nucleoside modification recognition. Enormous progress in understanding the strategies of nucleic acids catalysts has been made by providing thorough structural fundaments (e.g. first structure of a DNAzyme, structures of ribozyme transition state mimics) in combination with functional assays and atomic mutagenesis. KW - Functional nucleic acids KW - RNA Enzymes KW - RNA labeling KW - nucleoside modification recognition Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-212133 ET - Advance Article ER - TY - INPR A1 - Sednev, Maksim V. A1 - Liaqat, Anam A1 - Höbartner, Claudia T1 - High-Throughput Activity Profiling of RNA-Cleaving DNA Catalysts by Deoxyribozyme Sequencing (DZ-seq) T2 - Journal of the American Chemical Society N2 - RNA-cleaving deoxyribozymes have found broad application as useful tools for RNA biochemistry. However, tedious in vitro selection procedures combined with laborious characterization of individual candidate catalysts hinder the discovery of novel catalytic motifs. Here, we present a new high-throughput sequencing method, DZ-seq, which directly measures activity and localizes cleavage sites of thousands of deoxyribozymes. DZ-seq exploits A-tailing followed by reverse transcription with an oligo-dT primer to capture the cleavage status and sequences of both deoxyribozyme and RNA substrate. We validated DZ-seq by conventional analytical methods and demonstrated its utility by discovery of novel deoxyribozymes that allow for cleaving challenging RNA targets or the analysis of RNA modification states. KW - RNA-Cleaving Deoxyribozymes KW - High-Throughput Sequencing Method, DZ-seq KW - Analysis of RNA Modifications Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-258520 ER - TY - CHAP A1 - Liaqat, Anam A1 - Sednev, Maksim V. A1 - Höbartner, Claudia T1 - In Vitro Selection of Deoxyribozymes for the Detection of RNA Modifications T2 - Ribosome Biogenesis: Methods and Protocols N2 - Deoxyribozymes are artificially evolved DNA molecules with catalytic abilities. RNA-cleaving deoxyribozymes have been recognized as an efficient tool for detection of modifications in target RNAs and provide an alternative to traditional and modern methods for detection of ribose or nucleobase methylation. However, there are only few examples of DNA enzymes that specifically reveal the presence of a certain type of modification, including N6-methyladenosine, and the knowledge about how DNA enzymes recognize modified RNAs is still extremely limited. Therefore, DNA enzymes cannot be easily engineered for the analysis of desired RNA modifications, but are instead identified by in vitro selection from random DNA libraries using synthetic modified RNA substrates. This protocol describes a general in vitro selection stagtegy to evolve new RNA-cleaving DNA enzymes that can efficiently differentiate modified RNA substrates from their unmodified counterpart. KW - RNA KW - deoxyribozymes KW - modified RNA nucleotides KW - catalytic DNA KW - epitranscriptomics KW - in vitro selection KW - RNA cleavage Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-279208 SN - 978-1-0716-2501-9 PB - Humana Press ER - TY - JOUR A1 - Mieczkowski, Mateusz A1 - Steinmetzger, Christian A1 - Bessi, Irene A1 - Lenz, Ann-Kathrin A1 - Schmiedel, Alexander A1 - Holzapfel, Marco A1 - Lambert, Christoph A1 - Pena, Vladimir A1 - Höbartner, Claudia T1 - Large Stokes shift fluorescence activation in an RNA aptamer by intermolecular proton transfer to guanine JF - Nature Communications N2 - Fluorogenic RNA aptamers are synthetic functional RNAs that specifically bind and activate conditional fluorophores. The Chili RNA aptamer mimics large Stokes shift fluorescent proteins and exhibits high affinity for 3,5-dimethoxy-4-hydroxybenzylidene imidazolone (DMHBI) derivatives to elicit green or red fluorescence emission. Here, we elucidate the structural and mechanistic basis of fluorescence activation by crystallography and time-resolved optical spectroscopy. Two co-crystal structures of the Chili RNA with positively charged DMHBO+ and DMHBI+ ligands revealed a G-quadruplex and a trans-sugar-sugar edge G:G base pair that immobilize the ligand by π-π stacking. A Watson-Crick G:C base pair in the fluorophore binding site establishes a short hydrogen bond between the N7 of guanine and the phenolic OH of the ligand. Ultrafast excited state proton transfer (ESPT) from the neutral chromophore to the RNA was found with a time constant of 130 fs and revealed the mode of action of the large Stokes shift fluorogenic RNA aptamer. KW - Fluorogenic RNA Aptamers KW - Synthetic Functional RNAs KW - Chili RNA Aptamer KW - Co-Crystal Structures of Chili RNA KW - RNA KW - Optical Spectroscopy KW - Structural Biology KW - X-ray Crystallography Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-254527 VL - 12 ER - TY - JOUR A1 - Kabinger, Florian A1 - Stiller, Carina A1 - Schmitzová, Jana A1 - Dienemann, Christian A1 - Kokic, Goran A1 - Hillen, Hauke S. A1 - Höbartner, Claudia A1 - Cramer, Patrick T1 - Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis JF - Nature Structural & Molecular Biology N2 - Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir increases the frequency of viral RNA mutations and impairs SARS-CoV-2 replication in animal models and in humans. Here, we establish the molecular mechanisms underlying molnupiravir-induced RNA mutagenesis by the viral RNA-dependent RNA polymerase (RdRp). Biochemical assays show that the RdRp uses the active form of molnupiravir, β-d-\(N^4\)-hydroxycytidine (NHC) triphosphate, as a substrate instead of cytidine triphosphate or uridine triphosphate. When the RdRp uses the resulting RNA as a template, NHC directs incorporation of either G or A, leading to mutated RNA products. Structural analysis of RdRp–RNA complexes that contain mutagenesis products shows that NHC can form stable base pairs with either G or A in the RdRp active center, explaining how the polymerase escapes proofreading and synthesizes mutated RNA. This two-step mutagenesis mechanism probably applies to various viral polymerases and can explain the broad-spectrum antiviral activity of molnupiravir. KW - Molnupiravir KW - RNA-Dependent RNA Polymerase KW - SARS-CoV2 Replication Impairment KW - Molnupiravir-Induced RNA Mutagenesis Mechanism KW - Cryoelectron Microscopy Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-254603 VL - 28 ER - TY - JOUR A1 - Kokic, Goran A1 - Hillen, Hauke S. A1 - Tegunov, Dimitry A1 - Dienermann, Christian A1 - Seitz, Florian A1 - Schmitzova, Jana A1 - Farnung, Lucas A1 - Siewert, Aaron A1 - Höbartner, Claudia A1 - Cramer, Patrick T1 - Mechanism of SARS-CoV-2 polymerase stalling by remdesivir JF - Nature Communications N2 - Remdesivir is the only FDA-approved drug for the treatment of COVID-19 patients. The active form of remdesivir acts as a nucleoside analog and inhibits the RNA-dependent RNA polymerase (RdRp) of coronaviruses including SARS-CoV-2. Remdesivir is incorporated by the RdRp into the growing RNA product and allows for addition of three more nucleotides before RNA synthesis stalls. Here we use synthetic RNA chemistry, biochemistry and cryoelectron microscopy to establish the molecular mechanism of remdesivir-induced RdRp stalling. We show that addition of the fourth nucleotide following remdesivir incorporation into the RNA product is impaired by a barrier to further RNA translocation. This translocation barrier causes retention of the RNA 3ʹ-nucleotide in the substrate-binding site of the RdRp and interferes with entry of the next nucleoside triphosphate, thereby stalling RdRp. In the structure of the remdesivir-stalled state, the 3ʹ-nucleotide of the RNA product is matched and located with the template base in the active center, and this may impair proofreading by the viral 3ʹ-exonuclease. These mechanistic insights should facilitate the quest for improved antivirals that target coronavirus replication. KW - SARS-CoV-2 polymerase KW - Remdesivir KW - RNA-dependent RNA polymerase KW - Molecular mechanism KW - Biochemistry KW - Cryoelectron microscopy KW - RNA Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-220979 VL - 12 ER - TY - JOUR A1 - Liaqat, Anam A1 - Stiller, Carina A1 - Michel, Manuela A1 - Sednev, Maksim V. A1 - Höbartner, Claudia T1 - N\(^6\)-Isopentenyladenosine in RNA Determines the Cleavage Site of Endonuclease Deoxyribozymes JF - Angewandte Chemie International Edition N2 - RNA-cleaving deoxyribozymes can serve as selective sensors and catalysts to examine the modification state of RNA. However, site-specific endonuclease deoxyribozymes that selectively cleave posttranscriptionally modified RNA are extremely rare and their specificity over unmodified RNA is low. In this study, we report that the native tRNA modification N\(^6\)-isopentenyladenosine (i\(^6\)A) strongly enhances the specificity and has the power to reconfigure the active site of an RNA-cleaving deoxyribozyme. Using in vitro selection, we identified a DNA enzyme that cleaves i\(^6\)A-modified RNA at least 2500-fold faster than unmodified RNA. Another deoxyribozyme shows unique and unprecedented behaviour by shifting its cleavage site in the presence of the i\(^6\)A RNA modification. Together with deoxyribozymes that are strongly inhibited by i\(^6\)A, these results highlight intricate ways of modulating the catalytic activity of DNA by posttranscriptional RNA modifications. KW - Deoxyribozymes KW - Epitranscriptomics KW - in vitro selection KW - RNA modification KW - site-specific RNA cleavage Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-212121 ET - Early View ER -